ElendiLabs — Regulatory consultancy platform connecting medical device and pharmaceutical manufacturers with verified experts worldwide
All regulatory hubs
Regulatory hub

Overview of the National Agency for the Safety of Medicines and Health Products (ANSM) and Medical Device Regulation in France

An overview of the role of ANSM in France, focusing on market surveillance, clinical trial authorization, and the safety of medical devices under EU regulations.

Overview

Summary of this regulator or jurisdiction and how it relates to market access.

Official regulator site

National Agency for the Safety of Medicines and Health Products (ANSM) - France

The ANSM (Agence nationale de sécurité du médicament et des produits de santé) is the competent authority in France responsible for assessing the benefits and risks of health products throughout their life cycle. For medical devices, its primary role is to ensure patient safety through rigorous market surveillance and regulatory oversight.

1. Regulatory Mission and Authority

Unlike medicinal products, medical devices in France do not require a marketing authorization (MA) directly from the ANSM before entering the market. Instead, they must obtain a CE marking via a Notified Body. However, the ANSM intervenes in several critical areas:

  • Clinical Investigations: The ANSM evaluates and authorizes requests to conduct clinical trials for medical devices in France to ensure the protection of participants and the scientific validity of the data.
  • Market Surveillance: The agency monitors products already on the market through proactive controls and inspections of manufacturing sites.
  • Materiovigilance: This is the monitoring of incidents or risks of incidents resulting from the use of medical devices. The ANSM collects and analyzes reports from healthcare professionals, manufacturers, and patients.

2. Key Responsibilities

  • Incident Management: Taking corrective actions, such as withdrawing a product from the market or issuing safety alerts (Field Safety Notices).
  • Advertising Control: For certain high-risk medical devices, the ANSM must provide prior authorization for advertising intended for the public or professionals.
  • Implementation of EU Regulations: Ensuring the transition and strict compliance with the EU Medical Device Regulation (MDR) 2017/745 and the In Vitro Diagnostic Regulation (IVDR) 2017/746.

3. Collaboration

The ANSM works closely with the European Medicines Agency (EMA) and other national competent authorities within the EU to harmonize safety standards and respond to health crises effectively.

Articles & guides

Insight articles mapped to this region on ElendiLabs.

Other

January 11, 2026

Transitional Provisions for Medical Devices and IVDs in France under EU MDR/IVDR

The ANSM outlines transitional arrangements allowing continued marketing of certain medical devices and IVDs certified under the previous Directives (MDD/AIMDD/IVDD) in France during the extended MDR/IVDR transition periods, subject to specific conditions, validity extensions, and progressive compliance requirements to ensure patient safety during the shift to full MDR/IVDR application.

Read article

Other

January 7, 2026

Traceability Requirements for Medical Devices in France under EU MDR/IVDR

The ANSM outlines the traceability obligations for medical devices and IVDs in France under Regulations (EU) 2017/745 (MDR) and 2017/746 (IVDR), emphasizing Unique Device Identification (UDI), registration in EUDAMED, supply chain documentation, and vigilance reporting to ensure full product traceability from manufacturer to patient for safety and post-market surveillance.

Read article

Other

January 4, 2026

Custom-Made Medical Devices in France under EU MDR

The ANSM guidance details the regulatory framework for custom-made medical devices in France according to Regulation (EU) 2017/745 (MDR), including definition, specific obligations for manufacturers, documentation requirements, registration in EUDAMED, and exceptions from conformity assessment procedures to ensure patient safety for individually adapted devices.

Read article

Registration

December 19, 2025

Qualification and Classification of Medical Devices and IVDs in France (ANSM Reference)

The ANSM guidance details the qualification (when software or a product is considered a medical device or IVD) and classification rules in France, aligned with EU Regulation 2017/745 (MDR) and 2017/746 (IVDR), including decision trees, borderlines with other product categories, and specific considerations for software, AI, and combination products to support manufacturers in correct regulatory pathway determination.

Read article

Other

November 19, 2025

Impact of New EU Regulations on Software Classification as Medical Devices in France

The ANSM document explains how the transition from the Medical Devices Directive (MDD) to the Medical Device Regulation (MDR) significantly affects the classification of software, particularly moving many standalone software products from Class I (self-certification) to higher classes (IIa, IIb or III) under Rule 11, requiring notified body involvement and stricter conformity assessment for manufacturers in France.

Read article

Registration

July 19, 2025

Does Your Health Software or Mobile Application Qualify as a Medical Device or IVD in France?

The ANSM guidance helps determine if a health software or mobile app qualifies as a medical device (DM) or in vitro diagnostic medical device (DMDIV) under EU Regulations 2017/745 (MDR) and 2017/746 (IVDR), providing decision trees, examples, and key criteria based on intended purpose to assist developers and manufacturers in France with correct regulatory classification.

Read article

Registration

July 19, 2025

EUDAMED: Key Information for Medical Devices and IVDs in France (ANSM Overview)

The ANSM provides an overview of EUDAMED, the European database for medical devices and IVDs under Regulations (EU) 2017/745 and 2017/746, explaining mandatory registrations, actor roles, device identification (UDI), vigilance reporting, clinical investigations, and transitional provisions for legacy devices in France to support manufacturers and economic operators in compliance.

Read article

Registration

May 26, 2025

French Medical Device Market Entry Costs: Budgeting for EU MDR Compliance (€50K to €300K)

Entering the French medical device market requires budgeting between **€50,000 and €300,000**, primarily driven by **CE Marking certification fees** and the complexity of the device's classification. Key expenses include Notified Body fees, technical documentation, French translation, and annual **Authorized Representative** costs.

Read article

Post Market Surveillance

April 2, 2025

ANSM's Mission: Monitoring the Medical Device Lifecycle and Market Surveillance in France

The **ANSM** ensures the safety of medical devices in France by constantly monitoring the **benefit-risk balance** throughout their lifecycle. Its mission includes **market surveillance**, centralizing **vigilance** reports, controlling device advertising, conducting inspections, and enforcing corrective measures for non-compliance.

Read article

Registration

March 2, 2025

Medical Device Registration in France: Compliance with EU MDR and ANSM National Listing

France's medical device regulation is governed by the EU MDR. All devices require a **CE Mark** and must be registered locally with the national competent authority, the **ANSM**. Foreign manufacturers require an **EU Authorized Representative** to achieve market access.

Read article

Registration

February 2, 2025

Medical Device Registration in France: Compliance under the EU MDR and the ANSM

Medical device registration in France is governed by the EU Medical Device Regulation (EU MDR 2017/745). The national competent authority is the **ANSM**. Registration involves obtaining the mandatory **CE Mark** and ensuring data entry into the **EUDAMED** database.

Read article